PPARGC1A and diabetic kidney disease: For example, DHM was reported to mediate the AMPK-PGC-1a-SIRT3 signaling pathway to improve skeletal muscle insulin sensitivity [36] and promote autophagy by activating AMPK/mTOR signaling pathway, thereby reducing diabetic kidney injury and even delaying the progression of diabetic nephropathy [37].